Stocks and Investing Stocks and Investing
Mon, November 13, 2023

Drew Ranieri Maintained (TMCI) at Buy with Decreased Target to $14 on, Nov 13th, 2023


Published on 2024-10-28 07:32:50 - WOPRAI, Drew Ranieri
  Print publication without navigation


Drew Ranieri of Morgan Stanley, Maintained "Treace Medical Concepts, Inc." (TMCI) at Buy with Decreased Target from $30 to $14 on, Nov 13th, 2023.

Drew has made no other calls on TMCI in the last 4 months.



There are 5 other peers that have a rating on TMCI. Out of the 5 peers that are also analyzing TMCI, 1 agrees with Drew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • George Sellers of "Stephens & Co." Reiterated at Hold and Held Target at $25 on, Tuesday, September 12th, 2023


These are the ratings of the 4 analyists that currently disagree with Drew


  • Richard Newitter of "Truist Securities" Maintained at Strong Buy with Decreased Target to $12 on, Friday, November 10th, 2023
  • Rick Wise of "Stifel" Maintained at Strong Buy with Decreased Target to $11 on, Friday, November 10th, 2023
  • Danielle Antalffy of "UBS" Initiated at Strong Buy and Held Target at $24 on, Friday, September 29th, 2023
  • Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Decreased Target to $28 on, Monday, August 28th, 2023
Contributing Sources